Gene · 1844
Papers2,214
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,214
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparable effects of circuit and traditional resistance exercise on platelet α2bβ3 receptor and platelet activation and function. | Clin Hemorheol Microcirc | 2023 | 36565105 | PubTator, text mining | PubMed |
| Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment. | Blood Adv | 2023 | 36521029 | PubTator, text mining | PubMed |
| EXTRACELLULAR VESICLES AS REGULATORS OF IMMUNE FUNCTION IN TRAUMATIC INJURIES AND SEPSIS. | Shock | 2023 | 36516458 | PubTator, text mining | PubMed |
Stable CAD patients show higher levels of platelet-borne TGF-β1 associated with a superior pro-inflammatory state than the pro-aggregatory status; Evidence highlighting the importance of platelet-derived TGF-β1 in atherosclerosis. | J Thromb Thrombolysis | 2023 | 36352058 | PubTator, text mining | PubMed |
| Large extracellular vesicles secreted by human iPSC-derived MSCs ameliorate tendinopathy via regulating macrophage heterogeneity. | Bioact Mater | 2023 | 36101856 | PubTator, text mining | PubMed |
| COVID-19 immunopathology: From acute diseases to chronic sequelae. | J Med Virol | 2023 | 36056655 | PubTator, text mining | PubMed |
| Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19. | Blood Adv | 2023 | 36053793 | PubTator, text mining | PubMed |
| DUSP2 deletion with CRISPR/Cas9 promotes Mauthner cell axonal regeneration at the early stage of zebrafish. | Neural Regen Res | 2023 | 36018180 | PubTator, text mining | PubMed |
| The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM. | Blood | 2023 | 35984902 | PubTator, text mining | PubMed |
| Early expression of CD94 and loss of CD96 on CD8+ T cells after allogeneic stem cell tranplantation is predictive of subsequent relapse and survival. | Haematologica | 2023 | 35924575 | PubTator, text mining | PubMed |
| Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure. | Cell Biol Toxicol | 2023 | 35412187 | PubTator, text mining | PubMed |
| The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia. | Blood Adv | 2023 | 35358998 | PubTator, text mining | PubMed |
| Exosomes and cancer immunotherapy: A review of recent cancer research. | Front Oncol | 2022 | 36727049 | PubTator, text mining | PubMed |
| Anti-inflammatory properties of commonly used psychiatric drugs. | Front Neurosci | 2022 | 36704001 | PubTator, text mining | PubMed |
| Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV: A Randomized Controlled Trial. | JACC Basic Transl Sci | 2022 | 36687270 | PubTator, text mining | PubMed |
| Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders. | Front Oncol | 2022 | 36620555 | PubTator, text mining | PubMed |
| Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood. | Front Immunol | 2022 | 36591264 | PubTator, text mining | PubMed |
| circPOLR1C Promotes the Development of Esophageal Cancer by Adsorbing miR-361-3p and Regulating Cancer Cell Apoptosis and Metastasis. | J Oncol | 2022 | 36590309 | PubTator, text mining | PubMed |
| BCI, an inhibitor of the DUSP1 and DUSP6 dual specificity phosphatases, enhances P2X7 receptor expression in neuroblastoma cells. | Front Cell Dev Biol | 2022 | 36589747 | PubTator, text mining | PubMed |
| Flow cytometry for evaluating platelet immunophenotyping and function in patients with thrombocytopenia. | Tzu Chi Med J | 2022 | 36578648 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1844/papers?page=16